大健康公司向港交所递表 旗下品牌“谷本日记”20个月销售额达5亿

Xizi Health has submitted a listing application to the Hong Kong Stock Exchange, showcasing the rapid development and growth data of its health brands.

1. The company primarily offers sports nutrition and functional foods, including protein powder, complex whey protein powder, creatine, functional gummies, coffee, and other products.

2. Within its brand portfolio, fiboo, Guben Diary, and FoYes each achieved cumulative sales exceeding RMB 500 million within 31 months, 20 months, and 15 months post-launch respectively, demonstrating highly efficient operational strategies.

3. The new brand HotRule, launched in April 2025, has already achieved a cumulative GMV exceeding RMB 60 million, reflecting strong market acceptance for new products.

Significant revenue growth from its own brands provides a noteworthy success case study.

1. The revenue contribution from own brands increased sharply from 42.4% in 2023 to 97.3% for the nine months ended September 30, 2025, indicating a clear business transformation.

2. Own brand revenue grew remarkably, from RMB 613.7 million in 2023 to RMB 1,497.5 million in 2024 (a 144.0% increase), and further to RMB 1,566.5 million for the same period in 2025 (a 38.7% increase).

Highlights in brand marketing and product R&D reflect key health consumption trends.

1. The company has built a brand matrix including FoYes, fiboo, Guben Diary, and HotRule, covering needs from professional training to wellness lifestyles, showcasing the advantages of a multi-brand strategy.

2. Guben Diary reaching RMB 500 million in sales within 20 months demonstrates efficient brand channel development and strong user loyalty.

3. The strong sales of functional foods like protein powder and gummies indicate a consumer trend shift towards healthy lifestyles and a preference for efficient nutritional products.

Pricing and competitive strategies are evident in financial data, offering practical references.

1. The own brand revenue share rising to 97.3% suggests successful pricing strategies and strong price competitiveness.

2. The rapid growth of the new brand HotRule reflects product development closely aligned with the market, providing a model for fast iteration.

Clear growth market signals and opportunities, with own brand performance offering key learnings.

1. The health food market is experiencing rapid growth. Own brand revenue surged from RMB 613.7 million in 2023 to RMB 1,566.5 million for the same period in 2025, with annual growth exceeding 38.7%, indicating substantial potential.

2. Brands like Guben Diary achieving RMB 500 million in sales within 20 months demonstrate effective responses to shifting consumer demands, offering a model for rapid market entry.

Insights on new business models and risk warnings, highlighting the need to navigate industry competition.

1. HotRule's GMV exceeding RMB 60 million shortly after launch presents a successful case study of the latest business models, suggesting potential partnership opportunities.

2. High reliance on own brands (97.3% of revenue) signals risks, such as volatility from a single business line, necessitating diversification strategies.

Strong product demand and abundant commercial opportunities, with the shift to own brands providing strategic insights.

1. The company manufactures products like protein powder, complex whey protein, creatine, and functional gummies. Robust demand, exemplified by Guben Diary's RMB 500 million sales in 20 months, indicates opportunities for scaled production.

2. The increase in own brand revenue share from 42.4% to 97.3% suggests factories could focus on OEM opportunities or explore building their own brands.

Lessons in digitalization and e-commerce, based on sales data.

1. The rapid launch and growth of brands like HotRule (GMV >RMB 60 million in a short period) highlight the need for efficient production and digital supply chain management.

2. The substantial revenue growth data provides a template for e-commerce transformation, offering strategies for optimizing production capacity.

Clear industry development trends, with the health food sector gaining significant attention.

1. Xizi Health's listing application reflects the upward trajectory of the sports nutrition and functional food industry, where unmet health needs represent a key client pain point.

2. The rapid success of brands like fiboo and Guben Diary, with sales exceeding RMB 500 million, showcases effective marketing and product innovation as core solutions.

Indirect insights into new technologies and client pain points, inferred from data.

1. The high revenue growth of own brands (e.g., 144.0% YoY in 2024) suggests industry pain points like product homogeneity, which can be addressed through digital optimization solutions.

2. The swift launch of new brands reflects technology-driven production, providing a reference for service providers on data-supported operations.

Revelations for platform needs and operational management, based on own brand growth.

1. The rising share of own brand revenue (to 97.3%) indicates a platform need to support online sales channels, such as through merchant recruitment for e-commerce.

2. The rapid launch and success of brands like HotRule (GMV >RMB 60 million) offer insights into modern platform practices like efficient product listing and operational optimization.

Risk mitigation and partnership opportunities derived from financial data.

1. Significant revenue growth (e.g., 38.7% for the comparable period in 2025) suggests platform operations must mitigate risks like market saturation.

2. The success of the multi-brand strategy presents opportunities to explore platform collaborations, such as programs to incubate and support new brands.

New industry dynamics and business model innovation highlighted by the company's IPO move.

1. Xizi Health's application to list on the HKEX reflects growth trends in the sports nutrition industry, raising new questions such as the standardization of health consumption.

2. The business model transformation, with own brand contribution shifting from 42.4% to 97.3%, demonstrates strategic success and offers insights for policy and regulatory research.

Data supporting industry analysis, providing a case study for reference.

1. Brands like Guben Diary achieving RMB 500 million in sales within 20 months exemplify the efficiency of new business models, warranting deeper study into their replicability.

2. Financial data, such as annual revenue growth exceeding 38.7%, provides an empirical basis for research, suggesting future regulatory focus should include product quality.